Search Clinical Trials
598,375 trials
ID
Status
Phase
Title
Sponsor
NCT07766759
A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated TriglyceridesFosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.Not Yet RecruitingPhase 1
NCT07766759Not Yet Recruiting
Phase 1
A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglyceri...Fosun Pharmaceutical Indu...
NCT07765615
Study on Precision Dosing Strategies of Anti-infective Agents in the Very Early Stage of Kidney TransplantationFudan UniversityNot Yet Recruiting
NCT07765615Not Yet Recruiting
—
Study on Precision Dosing Strategies of Anti-infective Agents in the Very Early...Fudan University
NCT07764705
A Mass Balance Study of [14C]HS-10504Jiangsu Hansoh Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07764705Not Yet Recruiting
Phase 1
A Mass Balance Study of [14C]HS-10504Jiangsu Hansoh Pharmaceut...
NCT07766122
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFUUniversity Hospital, ToulouseNot Yet RecruitingPhase 4
NCT07766122Not Yet Recruiting
Phase 4
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostat...University Hospital, Toul...
NCT07766395
A Clinical Trial to Evaluate the Effects of a Powder Supplement in Supporting Lean Muscle Development, Hormone-Related Wellness, Digestive Comfort, Dermatologic Health, and Overall WellnessCitruslabsRecruitingNot Applicable
NCT07766395Recruiting
Not Applicable
A Clinical Trial to Evaluate the Effects of a Powder Supplement in Supporting Le...Citruslabs
NCT07766525
Complementary Music Therapy for Pain During Percutaneous Transluminal Angioplasty.Chang Gung Memorial HospitalCompletedNot Applicable
NCT07766525Completed
Not Applicable
Complementary Music Therapy for Pain During Percutaneous Transluminal Angioplast...Chang Gung Memorial Hospi...
NCT07764861
A Open-Label Phase in Participants With Multiple MyelomaInnovent Biologics (Suzhou) Co. Ltd.Not Yet RecruitingPhase 2
NCT07764861Not Yet Recruiting
Phase 2
A Open-Label Phase in Participants With Multiple MyelomaInnovent Biologics (Suzho...
NCT07765225
Ultrasonographic Evaluation of Cosmetic Keratolytic Treatment of Foot Calluses and CornsWroclaw University of Health and Sport SciencesCompletedNot Applicable
NCT07765225Completed
Not Applicable
Ultrasonographic Evaluation of Cosmetic Keratolytic Treatment of Foot Calluses a...Wroclaw University of Hea...
NCT07765043
Electromagnetic Therapy for Cervicogenic DysphagiaUmm Al-Qura UniversityCompletedNot Applicable
NCT07765043Completed
Not Applicable
Electromagnetic Therapy for Cervicogenic DysphagiaUmm Al-Qura University
NCT07765849
Online Sleep Education for College Student's Sleep Health and Executive FunctioningNorthern Arizona UniversityNot Yet RecruitingNot Applicable
NCT07765849Not Yet Recruiting
Not Applicable
Online Sleep Education for College Student's Sleep Health and Executive Function...Northern Arizona Universi...
NCT07764536
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital ToolNational Institute of Mental Health (NIMH)Not Yet Recruiting
NCT07764536Not Yet Recruiting
—
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital...National Institute of Men...
NCT07765524
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL AmyloidosisShenzhen Fosun Kairos Biotechnology Co., Ltd.Not Yet RecruitingPhase 1
NCT07765524Not Yet Recruiting
Phase 1
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the...Shenzhen Fosun Kairos Bio...
NCT07766187
Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic CholangiocarcinomaHistoSonics, Inc.Not Yet RecruitingPhase 2
NCT07766187Not Yet Recruiting
Phase 2
Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepat...HistoSonics, Inc.
NCT07766512
Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post-acute Sequalae of COVID-19 (PASC)Fondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07766512Not Yet Recruiting
—
Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post...Fondazione Policlinico Un...
NCT07765472
Subclinical Myocardial Dysfunction in Children With Wilson's DiseaseHebatullah FawzyActive Not Recruiting
NCT07765472Active Not Recruiting
—
Subclinical Myocardial Dysfunction in Children With Wilson's DiseaseHebatullah Fawzy
NCT07766265
NEST: A Group Intervention for Parents With Complex PTSDSt.Gallen University of Applied SciencesNot Yet RecruitingNot Applicable
NCT07766265Not Yet Recruiting
Not Applicable
NEST: A Group Intervention for Parents With Complex PTSDSt.Gallen University of A...
NCT07766369
A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy ParticipantsEisai Inc.Not Yet RecruitingPhase 1
NCT07766369Not Yet Recruiting
Phase 1
A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participa...Eisai Inc.
NCT07766291
Mapping the Neural Circuits of Depression and Anxiety Using Personalized, Accelerated TMS and Deep PhenotypingNational University Hospital, SingaporeNot Yet RecruitingNot Applicable
NCT07766291Not Yet Recruiting
Not Applicable
Mapping the Neural Circuits of Depression and Anxiety Using Personalized, Accele...National University Hospi...
NCT07765316
Targeting Pathogenic Myelopoiesis in Pancreatic CancerIRCCS San RaffaeleNot Yet Recruiting
NCT07765316Not Yet Recruiting
—
Targeting Pathogenic Myelopoiesis in Pancreatic CancerIRCCS San Raffaele
NCT07764757
Platelet-Rich Fibrin as an Antibiotic Delivery Vehicle in Mandibular Third Molar SurgeryAmerigo GiudiceActive Not RecruitingNot Applicable
NCT07764757Active Not Recruiting
Not Applicable
Platelet-Rich Fibrin as an Antibiotic Delivery Vehicle in Mandibular Third Molar...Amerigo Giudice
Result Breakdown
Not yet recruiting14 (70%)
Completed3 (15%)
Active, not recruiting2 (10%)
Recruiting1 (5%)
not_applicable8 (40%)
Not Specified5 (25%)
Phase 14 (20%)
Phase 22 (10%)
Phase 41 (5%)